Basic Considerations for the Use of Monoclonal Antibodies in Migraine

per Levin, Morris, Silberstein, Stephen D., Gilbert, Robert, Lucas, Sylvia, Munsie, Leanne, Garrelts, Alyssa, Kennedy, Kate, Everman, Nicole, Pearlman, Eric
Publicat a Headache (2018)

Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex

per Smith, Ryan M., Papp, Audrey C., Webb, Amy, Ruble, Cara L., Munsie, Leanne M., Nisenbaum, Laura K., Kleinman, Joel E., Lipska, Barbara K., Sadee, Wolfgang
Publicat 2012

Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

per Nisenbaum, Laura K., Downing, AnnCatherine M., Zhao, Fangyi, Millen, Brian A., Munsie, Leanne, Kinon, Bruce J., Adams, David H., Gomez, Juan Carlos, Penny, Michelle Ann
Publicat a J Pers Med (2016)

Gain and loss of function of P2X(7) receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain

per Ursu, Daniel, Ebert, Philip, Langron, Emily, Ruble, Cara, Munsie, Leanne, Zou, Wei, Fijal, Bonnie, Qian, Yue-Wei, McNearney, Terry A, Mogg, Adrian, Grubisha, Olivera, Merchant, Kalpana, Sher, Emanuele
Publicat 2014

Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons

per Ruble, Cara L., Smith, Ryan M., Calley, John, Munsie, Leanne, Airey, David C., Gao, Yuan, Shin, Joo Heon, Hyde, Thomas M., Straub, Richard E., Weinberger, Daniel R., Nisenbaum, Laura K.
Publicat a BMC Genet (2016)

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting

per Goldman, Jennifer G., Boeve, Bradley F., Armstrong, Melissa J., Galasko, Doug R., Galvin, James E., Irwin, David J., Leverenz, James B., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael C., Keller, Bill, Lai, Robert, Munsie, Leanne, Belleville, Michael, Chaney, Ondrea, Richard, Ian, Taylor, Angela, Graham, Todd
Publicat a Alzheimers Res Ther (2021)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

per Goldman, Jennifer G., Forsberg, Leah K., Boeve, Bradley F., Armstrong, Melissa J., Irwin, David J., Ferman, Tanis J., Galasko, Doug, Galvin, James E., Kaufer, Daniel, Leverenz, James, Lippa, Carol F., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael, Keller, Bill, Munsie, Leanne, Nakagawa, Masaki, Taylor, Angela, Graham, Todd
Publicat a Alzheimers Res Ther (2020)

Genome-wide association study of rate of cognitive decline in Alzheimer’s Disease patients identifies novel genes and pathways

per Sherva, Richard, Gross, Alden, Mukherjee, Shubhabrata, Koesterer, Ryan, Amouyel, Philippe, Bellenguez, Celine, Dufouil, Carole, Bennett, David A., Chibnik, Lori, Cruchaga, Carlos, del-Aguila, Jorge, Farrer, Lindsay A., Mayeux, Richard, Munsie, Leanne, Winslow, Ashley, Newhouse, Stephen, Saykin, Andrew J., Kauwe, John S.K., Crane, Paul K., Green, Robert C.
Publicat a Alzheimers Dement (2020)

Genetic Studies of Quantitative MCI and AD Phenotypes in ADNI: Progress, Opportunities, and Plans

per Saykin, Andrew J., Shen, Li, Yao, Xiaohui, Kim, Sungeun, Nho, Kwangsik, Risacher, Shannon L., Ramanan, Vijay K., Foroud, Tatiana M., Faber, Kelly M., Sarwar, Nadeem, Munsie, Leanne M., Hu, Xiaolan, Soares, Holly D., Potkin, Steven G., Thompson, Paul M., Kauwe, John S.K., Kaddurah-Daouk, Rima, Green, Robert C., Toga, Arthur W., Weiner, Michael W.
Publicat a Alzheimers Dement (2015)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers

per Shen, Li, Thompson, Paul M., Potkin, Steven G., Bertram, Lars, Farrer, Lindsay A., Foroud, Tatiana M., Green, Robert C., Hu, Xiaolan, Huentelman, Matthew J., Kim, Sungeun, Kauwe, John S. K., Li, Qingqin, Liu, Enchi, Macciardi, Fabio, Moore, Jason H., Munsie, Leanne, Nho, Kwangsik, Ramanan, Vijay K., Risacher, Shannon L., Stone, David J., Swaminathan, Shanker, Toga, Arthur W., Weiner, Michael W., Saykin, Andrew J.
Publicat 2013